Skip to Main Content

TARGET BP I Clinical Trial (TARGET BP I)

Conditions

Hypertension

Phase III

What is the purpose of this trial?

Brief Summary:

The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure controlled trial, comparing renal denervation performed with the Peregrine System Kit in the treatment group to the sham control group (without renal denervation - no alcohol infusion). Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central randomization

  • Trial with
    Ablative Solutions, Inc.
  • Start Date
    10/30/2019
  • End Date
    12/30/2020
Trial Image

For more information about this study, contact:

Lynn Wilson

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/04/2019
  • Study HIC
    #2000025879